Breaking News

You are here » Indian-Commodity  :  Mutual Funds  :  IIFL Mutual Fund introduces Capital Enhancer Fund-Series 1

23-Apr2018

IIFL Mutual Fund introduces Capital Enhancer Fund-Series 1

IIFL Mutual Fund launched the IIFL Capital Enhancer Fund-Series 1, an interval fund growth scheme. The NFO opens for subscription on April 23, 2018 and closes on May 04, 2018. No entry load and exit load will be applicable for the scheme. The minimum subscription amount is Rs 5,000.

The scheme's performance will be benchmarked against CRISIL Balance Fund – Aggressive Index and its fund manager is Prashasta Seth.

The investment objective of the scheme is to achieve long term capital appreciation by investing in equity and equity related securities, with strategy of hedging the portfolio with Nifty 50 Put Option and other Equity derivatives.


Related News

View all news

Reliance Mutual Fund introduces Fixed Horizon Fund-XXXX-Series 5

Reliance Mutual Fund has launched the Reliance Fixed Horizon Fund-XXXX-Series 5, a close ended income scheme. The NFO opens for subscription on December 11, 2018 and closes on December 13, 2018. No entry......

Franklin Templeton Mutual Fund introduces Fixed Maturity Plans-Series 5-Plan B (1244 days)

Franklin Templeton Mutual Fund has launched the Franklin India Fixed Maturity Plans-Series 5-Plan B (1244 days), a close ended debt scheme. The NFO opens for subscription on November 19, 2018 and closes......

Aditya Birla Sun Life Mutual Fund introduces Fixed Term Plan-Series QQ (1100 days)

Aditya Birla Sun Life Mutual Fund has launched the Aditya Birla Sun Life Fixed Term Plan-Series QQ (1100 days), a close ended income scheme. The NFO opens for subscription on August 20, 2018 and closes......

Top News

View all news

RPP Infra Projects bags orders worth Rs 62.90 crore from BHEL

RPP Infra Projects has bagged orders from Bharat Heavy Electricals (BHEL), Chennai for worth of Rs 62.90 crore. The first order is for providing civil works of Boiler, Mill and Bunker, ESP area of unit......

Glenmark gets tentative ANDA approval for Abiraterone Acetate Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate Tablets USP, 250 mg, a generic......

HDFC Standard Life Insurance reports 18% rise in Q3 net profit

HDFC Standard Life Insurance has reported results for third quarter ended December 31, 2018. The company has reported a rise of 18.48% in its net profit at Rs 245.63 crore for the quarter under review......